Researchers Submit Patent Application, 'Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy', for Approval (USPTO 20240133877)

Source :: AIDS Weekly. May 13, 2024, 1351
Publication Year :: 2024
Abstract: 2024 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DAUGHTRIDGE, Giffin [...]

Subjects :: Product introduction
Intellectual property
Methods
Nucleosides -- Product introduction -- Intellectual property
HIV infections -- Methods
Emtricitabine -- Product introduction -- Intellectual property
DNA polymerases -- Methods
Patient compliance -- Methods
HIV infection -- Methods

Tools